Revascularisation for Ischaemic Cardiomyopathy

Revascularisation for Ischaemic Cardiomyopathy

Coronary artery disease is a leading cause of heart failure with reduced ejection fraction. Coronary artery bypass grafting appears to provide clinical benefits such as improvements in quality of life, reductions in readmissions and MI, and favourable effects on long-term mortality; however, there i...

Full description

Bibliographic Details
Main Authors:	Matthew E Li Kam Wa, Saba Z Assar, Ajay J Kirtane, Divaka Perera
Format:	Article
Language:	English
Published:	Radcliffe Medical Media 2023-08-01
Series:	Interventional Cardiology: Reviews, Research, Resources
Online Access:	https://www.icrjournal.com/articleindex/icr.2023.06

Similar Items

Surgical revascularisation of the heart in patients with chronic ischaemic cardiomyopathy and left ventricular ejection fraction of less than 30%
by: Velinović Miloš, et al.
Published: (2005-01-01)

Left ventricular volume change and long-term outcomes in ischaemic cardiomyopathy with or without surgical revascularisation: A post-hoc analysis of a randomised controlled trial
by: Zhuoming Zhou, et al.
Published: (2022-11-01)

Coronary revascularisation.
by: Taggart, D
Published: (2007)

The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
by: Tom Nelson, et al.
Published: (2019-01-01)

Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
by: Jiří Plášek, et al.
Published: (2024-01-01)

Epidemiology and indications for revascularisation of carotid stenoses
by: Gaba, KA, et al.
Published: (2017)

Revascularisation for acute coronary syndromes: PCI or CABG?
by: Gunn, J, et al.
Published: (2003)

Revascularisation for atherosclerotic renal artery stenosis: Is it worthwhile?
by: T J Nirmal, et al.
Published: (2010-01-01)

Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
by: Jiří Plášek, et al.
Published: (2024-04-01)

ANTIOXIDANT EFFECT OF MILDRONATE IN PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-02-01)

The 2010 ESC/EACTS guidelines on myocardial revascularisation.
by: Taggart, D, et al.
Published: (2011)

Is there equity of access to revascularisation in Wales by socioeconomic deprivation?
by: Lloyd Evans
Published: (2019-11-01)

Wound-directed revascularisation in the Diabetic Foot patients
by: Danylo Shapovalov, et al.
Published: (2021-10-01)

Wound-directed revascularisation in the Diabetic Foot patients
by: N. Kononenko, et al.
Published: (2016-06-01)

Recapitulation of developmental mechanisms to revascularise the ischemic heart
by: Dube, K, et al.
Published: (2017)

Anaesthesia for myocardial revascularisation in a patient with portal hypertension.
by: Khanvelkar K, et al.
Published: (2002-01-01)

Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy
by: Ling Kuo, et al.
Published: (2020-01-01)

EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry
by: Charles B L M Majoie, et al.
Published: (2021-08-01)

Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy
by: Mengbo Li, et al.
Published: (2020-06-01)

Revascularisation of coronary artery disease in patients with diabetes mellitus
by: Swiss Medical Weekly
Published: (2009-11-01)

Algorithmic surgical enhancement of function after finger revascularisation
by: Luis Landin, et al.
Published: (2016-05-01)

The assessment of ischaemic burden: validation of a "functional" jeopardy score against cardiovascular magnetic resonance
by: Hussain Shazia T, et al.
Published: (2013-01-01)

Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies
by: Parsai Chirine, et al.
Published: (2012-08-01)

A Case Report on Ischaemic Cardiomyopathy with Severe Left Ventricular Dysfunction
by: Mohammed Misbah Ul Haq, et al.
Published: (2021-10-01)

Left ventricular reverse remodelling and its predictors in non‐ischaemic cardiomyopathy
by: Tomas Hnat, et al.
Published: (2022-08-01)

Incidence, prognosis, and prediction of haemorrhagic transformation after revascularisation for stroke
by: P.B. García Jurado, et al.
Published: (2021-10-01)

Underdiagnosed Roifman syndrome manifested as non‐ischaemic cardiomyopathy: a case report
by: Qianlan Xi, et al.
Published: (2023-10-01)

Clonal haematopoiesis of indeterminate potential‐related mutations and outcome in dilated and ischaemic cardiomyopathy
by: Jasmine M.F. Wu, et al.
Published: (2022-12-01)

Therapeutic effects of revascularisation on the healing of free bone grafts in dogs
by: Zheng Jia-San, et al.
Published: (2020-03-01)

Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base
by: Martin Lowe, et al.
Published: (2020-06-01)

Individualised evaluation based on pathophysiology for moyamoya vasculopathy: application in surgical revascularisation
by: Xin Zhang, et al.

Upper Extremity Blood Pressure Difference in Patients Undergoing Carotid Revascularisation
by: Huibers, A, et al.
Published: (2017)

Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265].
by: Taggart, D, et al.
Published: (2006)

Endovascular revascularisation versus surgical revascularisation in patients with lower limb atherosclerosis obliterans: a protocol for systematic review and meta-analysis with trial sequential analysis and meta-regression
by: Peng Qiu, et al.
Published: (2022-12-01)

Minimally Invasive Coronary Revascularisation Surgery: A Focused Review of the Available Literature
by: Karel M Van Praet, et al.
Published: (2021-05-01)

PREVENTIVE MYOCARDIAL REVASCULARISATION BEFORE ABDOMINAL AORTIC INTERVENTIONS: LONG-TERM RESULTS
by: A. N. Sumin, et al.
Published: (2013-12-01)

Are Grey Zones in Preferred Initial Revascularisation Strategies for Infra-Inguinal Peripheral Artery Disease Really Grey?
by: Ali Baran Budak, et al.
Published: (2022-01-01)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
by: Roland R Tilz, et al.
Published: (2019-01-01)

Combined evaluation of right ventricular function using echocardiography in non‐ischaemic dilated cardiomyopathy
by: Jumpei Ishiwata, et al.
Published: (2021-10-01)

Does a hybrid approach to multivessel revascularisation really make sense?
by: Taggart, D
Published: (2013)